Alan P. Farwell

Alan P. Farwell

Auto-generated profile, based on publicly available information

Alan P. Farwell

Section of Endocrinology, Diabetes, Nutrition and Weight Management, Boston University Chobanian & Avedisian School of Medicine, Boston Medical Center, Boston, MA, USA

Research Focus & Metrics

Academic Career Length

44Years (1983-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2003 in New England Journal of Medicine
Verified
Journal Article
Closed access
EPElizabeth N. Pearce
Elizabeth N. Pearce
AFAlan P. Farwell
Alan P. Farwell
LBLewis E. Braverman
Lewis E. Braverman
This article summarizes the current understanding of the mechanisms of destruction in autoimmune thyroid disease. The authors explain the approach to the diagnosis and treatment of the most common types of thyroiditis, including Hashimoto's thyroiditis, painless postpartum thyroiditis, and painless sporadic thyroiditis. Thyroid dysfunction can also develop from treatment with medications such as amiodarone, lithium, interferon alfa, and interleukin-2.

15 March 2016
Verified
Book Chapter
Closed access
PDF file
SLSun Lee
Sun Lee
AFAlan P. Farwell
Alan P. Farwell

1 January 2005 in Developmental Brain Research
Verified
Journal Article
Closed access
AFAlan P. Farwell
Alan P. Farwell
SDSusan A. Dubord-Tomasetti
Susan A. Dubord-Tomasetti
APAndrzej Z. Pietrzykowski
Andrzej Z. Pietrzykowski
SSStanley J. Stachelek
Stanley J. Stachelek
JLJack L. Leonard
Jack L. Leonard

1 June 1993 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
JCJean-Pierre Chanoine
Jean-Pierre Chanoine
LBL E Braverman
L E Braverman
AFA P Farwell
A P Farwell
MSM Safran
M Safran
SAS Alex
S Alex
JLJ L Leonard
J L Leonard
In rats, the respective contribution of the thyroid and peripheral tissues to the pool of T3 remains unclear. Most, if not all, of the circulating T3 produced by extrathyroidal sources is generated by 5'-deiodination of T4, catalyzed by the selenoenzyme, type I iodothyronine 5'-deiodinase (5'D-I). 5'D-I in the liver and kidney is almost completely lost in selenium deficiency, resulting in a marked decrease in T4 deiodination and an increase in circulating T4 levels. Surprisingly, circulating T3 levels are only marginally decreased by selenium deficiency. In this study, we used selenium deficiency and thyroidectomy to determine the relative contribution of thyroidal and extrathyroidal sources to the total body pool of T3. Despite maintaining normal serum T4 concentrations in thyroidectomized rats by T4 replacement, serum T3 concentrations remained 55% lower than those seen in intact rats. In intact rats, restricting selenium intake had no effect on circulating T3 concentrations. Decreasing 5'D-I activity in the liver and kidney by > 90% by restricting selenium intake resulted in a further 20% decrease in serum T3 concentrations in the thyroidectomized, T4 replaced rats, suggesting that peripheral T4 to T3 conversion in these tissues generates approximately 20% of the circulating T3 concentrations. While dietary selenium restriction markedly decreased intrahepatic selenium content (> 95%), intrathyroidal selenium content decreased by only 27%. Further, thyroid 5'D-I activity actually increased 25% in the selenium deficient rats, suggesting the continued synthesis of this selenoenzyme over selenoproteins in other tissues in selenium deficiency. These data demonstrate that the thyroid is the major source of T3 in the rat and suggest that intrathyroidal T4 to T3 conversion may account for most of the T3 released by the thyroid.

1 October 2013 in Current Opinion in Endocrinology, Diabetes and Obesity
Verified
Journal Article
Closed access
AFAlan P. Farwell
Alan P. Farwell
The current state of the pathophysiology, diagnosis, and therapeutic implications of the nonthyroidal illness syndrome is reviewed. Previous studies attributed the development of the nonthyroidal illness syndrome to alterations in three main areas of thyroid hormone metabolism: deiodinase activity, thyroid-stimulating hormone secretion, and hormone binding to serum proteins. New studies suggest that alterations in thyroid hormone transport into tissues and alterations of the nuclear thyroid hormone receptors may also play a role. Therapy of the nonthyroidal illness syndrome remains a controversial topic. Multiple factors lead to the development of the nonthyroidal illness syndrome, including alterations in type 1 and 3 deiodinase activity, thyrotropin-releasing hormone and thyroid-stimulating hormone secretion, hormone binding to plasma proteins, thyroid hormone transporter expression and activity, and the thyroid hormone nuclear receptor complex. These data show that acute and chronic illness affect all aspects of thyroid hormone metabolism and action. Some of these changes are physiologic and some are pharmacologic. The mediators of these alterations are still largely unclear. There continues to be no indication for thyroid hormone therapy in the vast majority of patients with the nonthyroidal illness syndrome, although interesting data suggest a possible role for treating a small subset of patients.

1 February 1997 in Thyroid®
Verified
Journal Article
Closed access
JLJack L. Leonard
Jack L. Leonard
AFAlan P. Farwell
Alan P. Farwell
Thyroid hormones play an important role in the growth and development of the brain. Central to the proper integration of neuronal circuitry is the ability of the growing neurite to interpret guidance cues during its migration. The actin cytoskeleton is especially rich in the growth cone, and is a likely target for thyroid hormone regulation. This brief review summarizes work showing that thyroxine, but not T3, dynamically regulates the polymerization of the actin cytoskeleton in astrocytes. The ability of T4 to enhance actin polymerization, without directly affecting gene expression, has a profound effect on the ability of the cell to interact with laminin, the major extracellular matrix protein in the developing brain. T4 also regulates the formation of key cell contacts with extracellular matrix guidance cues. These processes are likely to participate in thyroid hormone's regulation of brain development.